Morning Market Losers

shares slipped 69.74 percent to $1.05 after the company reported a regulatory update. Sunesis Pharmaceuticals has been informed that the FDA will not support recent Vosaroxin filing.

shares dropped 31.33 percent to $17.05. Spectranetics reported a Q2 loss of $0.17 per share on revenue of $61.7 million. The company expected FY adjusted loss of $0.96 per share to $0.70 per share and revenue of $240 million to $250 million.

shares dipped 37.73 percent to $6.65 after the company issued a weak forecast for second quarter and FY15.

shares declined 15.66 percent to $324.76. Biogen reported better-than-expected earnings for the second quarter, but the company's revenue missed analysts' estimates. The company also lowered its FY15 forecast.

shares slipped 14.82 percent to $11.90. Abengoa is expected to release its financial results for the first half of 2015 on Friday July 31st, 2015. The company reported that it has closed the financing for the first public private partnership project in Uruguay.

declined 13.95 percent to $3.33. Aware reported a Q2 loss of $0.01 per share on revenue of $4.5 million.

fell 12.06 percent to $55.34. Cepheid reported a Q2 loss of $0.23 per share on revenue of $132.5 million.

shares dropped 9.83 percent to $84.19 after the company reported weaker-than-expected Q2 results.